跳至主要内容
临床试验/NCT06565364
NCT06565364已完成不适用

Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients

Medical University of Vienna1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2019年1月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
160
试验地点
1
主要终点
prevalence of protamine/heparin antibodies

研究概览

简要总结

The primary aim of this study was to describe the prevalence and time course of the occurrence of protamine/heparin antibodies in patients undergoing cardiac surgery on cardiopulmonary bypass.

The second aim was to identify triggers of immunization.

The third aim of this study was to evaluate a potential clinical impact of protamine/heparin antibodies and their platelet-activating properties leading to thromboembolism and other adverse outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥ 18 years
  • cardiac surgery on cardiopulmonary bypass

排除标准

  • cardiac surgery without cardiopulmonary bypass
  • age < 18 years
  • no written consent

结局指标

主要结局

prevalence of protamine/heparin antibodies

时间窗: preoperatively until postoperative day 10

次要结局

  • Potential triggers(preoperatively)
  • Clinical impact(until postoperative day 10)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Caroline Holaubek, MD

Medical Doctor, Research Fellow

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验